Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma

Hypoxia is a predominant feature in glioblastoma (GBM) and contributes greatly to its drug resistance. However, the molecular mechanisms which are responsible for the development of the resistant phenotype of GBM under hypoxic conditions remain unclear. To analyze the key pathways promoting therapy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Oncol
Hauptverfasser: Gao, Yixing, Liu, Bao, Feng, Lan, Sun, Binda, He, Shu, Yang, Yidong, Wu, Gang, E, Guoji, Liu, Chang, Gao, Yuqi, Zhang, Erlong, Zhu, Bo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6367651/
https://ncbi.nlm.nih.gov/pubmed/30775317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00033
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge